Siemens wins FDA clearance for ‘smart’ mammography workflow software
Siemens Healthineers has won federal clearance for two new mammography workflow solutions that it says will enhance breast screening care for women around the globe.
The U.S. Food and Drug Administration announced its decision to greenlight Siemen’s Mammovista B.smart reading platform and dashboard on Monday, Nov. 22. The solution offers a tool for quicker breast imaging interpretations and an artificial intelligence-powered mechanism to help spot cancerous regions on exams.
“These latest offerings optimize radiologist workflow and can help healthcare institutions standardize their fleet of mammography systems, supporting the larger goal of optimizing breast cancer care for every woman,” added Niral Patel, vice president of X-ray products at Siemens Healthineers North America.
Radiologists using the software require fewer clicks during breast imaging tasks and image load speeds 75% quicker than other methods, the health giant said.
Siemens also touted the system’s artificial intelligence-enabled workflows which detect tissue abnormalities during radiologists’ interpretations. The workflow includes a confidence score reflecting the algorithm’s accuracy when highlighting cancerous areas.
“Mammovista B.smart and teamplay Mammo Dashboard are powerful additions to the holistic breast health portfolio of Siemens Healthineers, which covers every step along a woman’s breast health journey,” Patel added Monday.
Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.